Clinical Trials Logo

Breast Conserving Surgery clinical trials

View clinical trials related to Breast Conserving Surgery.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05946759 Completed - Clinical trials for Breast-Conserving Surgery

Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessment

SHIELD
Start date: October 10, 2023
Phase: N/A
Study type: Interventional

This PMPF study is proposed to evaluate in real life the reoperation rates (ROR) of breast cancer and/or DCIS surgery when including the use of the HLS in the context of breast lumpectomy margin assessment.

NCT ID: NCT05100914 Completed - Breast Cancer Clinical Trials

Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast Cancer

Start date: March 14, 2019
Phase: N/A
Study type: Interventional

The women with breast cancer and their spouses experienced physical and mental distresses together, nevertheless, the spouses were the significant supporters for patients during post-surgery rehabilitation. Based on the patient and family-centered care (PFCC), it was hypothesized that the couple engages in post-surgery rehabilitation could help women to have an improved shoulder range of movement, quality of life, and couples have better marital intimacy. All the women were eligible to be included in the randomized control trial if diagnosed with breast cancer, received breast surgery, her spouses were accompanying, and gave written consents. Women were randomized into two groups. The control group continues to receive usual care. The experimental group, who received couple-based family nursing (30-60 minutes couple-based interviews) based on the core concepts of PFCC: dignity and respect, information sharing, participation, and collaboration. The study nurse empowered spouses to assist the women's daily rehabilitation with a special workbook by clear pictures demonstration.

NCT ID: NCT04858282 Completed - Breast Cancer Clinical Trials

Application-Enabled Shared Decision-Making

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

To develop application-enabled shared decision-making among patients with early breast cancer and evaluate the preliminary effects of the interventions.

NCT ID: NCT04487561 Completed - Breast Cancer Clinical Trials

Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy

REDHEMOPACH
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Aspirative drainage continues to be the "gold standard" for the management of this post-surgical complication, even though it can lead to complications such as obstruction of the drainage, peritubal leakage of the seroma, etc. This may result in pain and reduction in mobility of the affected arm. Based on our positive clinical outcomes and the fact that there is not any published data available in the literature regarding this use of the patch, the investigators propose a multicentric, randomized controlled clinical trial, with the objective of comparing the Hemopatch® with the usual technique used (aspirative drainage) in terms of efficacy and safety. Hypothesis: Placing a Hemopatch ® instead of an aspirative drainage in women after undergoing axillary lymph node dissection during breast cancer surgery may reduce the appearance of seroma and consequently the need for a puncture, as well as the complications related to aspirative drainage.

NCT ID: NCT04092842 Completed - Clinical trials for Breast Conserving Surgery

Evaluation of a New Technique to Fill the Defect Generated After Conservative Surgery in Breast Cancer

PROSILMA
Start date: September 18, 2019
Phase: N/A
Study type: Interventional

The placement of a small silicone prosthesis in the partial defects generated by conservative breast cancer surgery improves the aesthetic result, compared to the usual surgical technique, in a safe and reproducible way and compatible with adjuvant treatments. It could also potentially improve the quality of life of patients

NCT ID: NCT02809729 Completed - Breast Neoplasms Clinical Trials

Antibiotic Prophylaxis in Oncological Surgery of Breast

Start date: January 2015
Phase: N/A
Study type: Interventional

Breast cancer is the most frequent malignancy in the female population Brazilian, except non-melanoma skin tumors. Surgery plays an important role in regional spot disease control and the definition of parameters for the adjuvant treatment indication. Surgical site infections (SSI) are defined as wound infections occur following invasive procedures, corresponding to 14-16% of all infections nosocomial in hospitalized patients, the most common among patients surgical. SSIs should be examined as potential wound contamination surgical, understood as the number of micro-organisms in the body and / or tissue being operated. Considering this aspect, the cancer surgery breast are classified by their potential for contamination by clean. The use of antibiotics to prevent the SSI in mastectomies is not standardized in Handbook of National Health Surveillance Agency due to the effectiveness of undocumented prophylaxis Thus the use of antibiotics may vary among services. So this randomized clinical trial to evaluate the influence of the use of Prophylactic antibiotics in SSI rates in oncological breast surgery.